ReviewCancer chemotherapy and pharmacology2022

An update on antibody-drug conjugates in urothelial carcinoma: state of the art strategies and what comes next.

Alberto D'Angelo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.